HUM Humana Inc. Common Stock

NYSE · Health Care · View on SEC EDGAR ↗
$382.25
Price · Aug 19, 2026
Fundamentals as of Jul 29, 2026

About Humana Inc. Common Stock Company overview from Wikipedia

Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked company based in Kentucky. It is the fourth largest health insurance provider in the U.S.

Read more

Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked (by revenues) company based in Kentucky. It is the fourth largest health insurance provider in the U.S.

History

1961–1983: Nursing homes and hospitals

Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).

In 1974, the partners changed the corporate name to Humana Inc. The name was meant to change public perception from 'warehousing' or indifferently treating people to providing a higher level of human care and, by extension, more humane care. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s. During this period, Humana developed the double corridor model for hospital construction. This design minimized the distance between patients and nurses by placing nursing support services in the interior of the building with patient rooms surrounding the perimeter.

1984–present

As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."

In 1993, Humana had become the largest hospital operator in the country, owning 77 hospitals. Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.

In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value. In 2001, Humana was a cofounder of Availity.

In 2005, Humana entered into a business partnership with Virgin Group, offering financial incentives to members for healthy behavior, such as regular exercise.

On November 16, 2006, the Centers for Disease Control and Prevention (CDC) and Humana Inc. partnered to expand on traditional private-sector approaches to population health management.

In 2010, Humana bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million, effectively returning to healthcare services. In May 2011, Humana announced it would be using mobileStorm to transmit protected health information to patients.

In March 2015, Humana announced the sale of Concentra to private equity firm Welsh, Carson, Anderson & Stowe and Select Medical Holdings Corporation for about $1 billion, with proceeds to fund a "$2 billion share buyback program and other corporate spending."

In July 2015, Aetna announced that it would acquire Humana for $37 billion in cash and stock (approximately $230 a share at that time). Aetna and Humana shareholders would own 74% and 26% of the new combined company. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna Inc. and Humana Inc. quashed a $34 billion merger agreement after judges ruled against the merger for a second time.

In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million. In August 2018, Humana announced the creation of a digital health and analytics division called Humana Studio H.

In December 2019, the company announced it would acquire Enclara Healthcare from Consonance Capital Partners and Enclara management.

In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO. Her appointment to the position comes with the company's focus being turned towards the home healthcare business, acquiring in April of the same year a 60% stake in Kindred at Home, an in-home care and hospice business.

In April 2022, it was announced Humana would sell a 60% interest of its Kindred at Home division to the private investment company, Clayton, Dubilier & Rice, for US$2.8 billion.

In February 2023, Humana announced they were exiting the employer-based commercial group insurance market.

Corporate affairs

Sponsorship

Humana is the presenting sponsor of the Grand Ole Opry and the National Senior Games.

Since 1979, Humana has been a principal sponsor of the annual Humana Festival of New American Plays in Louisville, Kentucky.

Humana was a tour partner of the PGA Tour beginning from 2005 to 2015.

The Humana Distaff Handicap is a Grade 1 race for thoroughbred fillies and mares, four-years-old and up. The race is run each spring on Kentucky Derby day at Churchill Downs and set at a distance of 7 furlongs for a purse of $250,000.

Humana Military Healthcare Services

In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.

From 2004 to 2009, HMHS was the managed care contractor for the Department of Defense Military Health System TRICARE South Region.

In 2009, HMHS' Managed Care Support Contract was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.

In 2011, HMHS regained the five-year contract to administer medical benefits to military members and families in the South region, a contract worth $23.5 billion. In 2018, this was moved to the new TRICARE East region during the TRICARE regional realignment.

On December 22, 2022, the Department of Defense announced the award of the managed care support contract for the TRICARE East Region to Humana Military.

Legal campaign against drug price fixing

Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.

Controversy

In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.

On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.

In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.

Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.

On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

HUM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$382.25
Market Cap
$75.96B
P/E (TTM)
38.8
EPS (TTM)
$9.84
Revenue (TTM)
$129.66B
Div Yield
0.56%
ROE
7.0%
Debt/Equity
0.7
52W Range
$163 – $429

HUM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $129.66B
10-point trend, +138.4%
2016-12-31 2025-12-31
EPS $9.84
10-point trend, +141.8%
2016-12-31 2025-12-31
Free Cash Flow $375M
10-point trend, -73.4%
2016-12-31 2025-12-31
Margins 0.92%

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
HUM
Peer Median
P/E (TTM)
5-point trend, +27.2%
38.8
36.8
P/S (TTM)
4-point trend, -64.2%
0.6
0.8
P/B
4-point trend, -56.6%
4.3
3.4
EV / EBITDA
4-point trend, -33.7%
25.3
Price / FCF
4-point trend, +362.5%
202.6

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
HUM
Peer Median
Operating Margin
5-point trend, -44.9%
2.1%
Net Profit Margin
5-point trend, -73.9%
0.92%
0.85%
ROA
5-point trend, -66.3%
2.5%
2.8%
ROE
5-point trend, -61.5%
7.0%
8.2%
ROIC
5-point trend, -26.6%
7.4%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
HUM
Peer Median
Debt / Equity
5-point trend, +7.0%
0.7
Current Ratio
5-point trend, +23.3%
2.0
1.5
Quick Ratio
5-point trend, +18.1%
1.4

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
HUM
Peer Median
Revenue YoY
5-point trend, +56.1%
10.1%
Revenue CAGR 3Y
5-point trend, +56.1%
11.8%
Revenue CAGR 5Y
5-point trend, +56.1%
10.9%
EPS YoY
5-point trend, -56.6%
-1.4%
Net Income YoY
5-point trend, -59.5%
-1.6%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
HUM
Peer Median
EPS (Diluted)
5-point trend, -56.6%
$9.84

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
HUM
Peer Median
Payout Ratio
5-point trend, +199.9%
36.2%

Dividends Yield, payout ratio, dividend history, 5Y CAGR

Dividend Yield
0.56%
Payout Ratio
36.2%
5Y Div CAGR
Ex-dateAmount
June 26, 2026$0.8850
March 27, 2026$0.8850
Dec. 26, 2025$0.8850
Sept. 26, 2025$0.8850
June 27, 2025$0.8850
March 28, 2025$0.8850
Dec. 31, 2024$0.8850
Sept. 30, 2024$0.8850
June 28, 2024$0.8850
March 27, 2024$0.8850
Dec. 28, 2023$0.8850
Sept. 28, 2023$0.8850
June 29, 2023$0.8850
March 30, 2023$0.8850
Dec. 29, 2022$0.7880
Sept. 29, 2022$0.7880
June 29, 2022$0.7880
March 30, 2022$0.7880
Dec. 30, 2021$0.7000
Sept. 29, 2021$0.7000

HUM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 33 analysts
  • Strong Buy 8 24.2%
  • Buy 8 24.2%
  • Hold 15 45.5%
  • Sell 2 6.1%
  • Strong Sell 0 0.0%

12-Month Price Target

23 analysts · 2026-08-19
Median target $415.00 +8.6%
Mean target $416.43 +8.9%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.42%
Period EPS Actual EPS Est Surprise
June 30, 2026 $7.61 $7.29 0.32%
March 31, 2026 $10.31 $10.29 0.02%
Dec. 31, 2025 $-3.96 $-4.05 0.09%
Sept. 30, 2025 $3.24 $2.85 0.39%
June 30, 2025 $6.27 $5.98 0.29%
March 31, 2025 $11.58 $10.17 1.4%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
HUM $50.90B 26.0 10.1% 0.92% 7.0%
UNH $299.08B 25.0 11.8% 2.7% 12.0%
ELV $77.37B 13.9 12.5% 2.8% 13.3%
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9%
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
ALHC $4.03B 46.1% -0.02% -0.52%
CLOV -5.1 40.3% -4.5% -26.2%
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 13
Annual Income Statement data for HUM
Metric Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +167.3% $129.66B $117.76B $106.37B $92.87B $83.06B $77.16B $64.89B $56.91B $53.77B $54.38B $54.29B $48.50B
SG&A Expense 12-point trend, +102.3% $15.45B $13.70B $13.19B $12.67B $10.12B $10.05B $7.38B $7.53B $6.57B $7.17B $7.29B $7.64B
Operating Income 12-point trend, +14.5% $2.70B $2.56B $4.01B $3.80B $3.15B $4.99B $3.19B $3.10B $4.26B $1.74B $2.35B $2.36B
Interest Expense 10-point trend, +156.8% · · $493M $401M $326M $283M $242M $218M $242M $189M $186M $192M
Other Non-op 10-point trend, -451000000.00 $-451M $-181M $-137M $-68M $532M $-103M $506M $-33M $0 $0 · ·
Pretax Income 12-point trend, -33.7% $1.44B $1.62B $3.33B $3.57B $3.42B $4.67B $3.47B $2.07B $4.02B $1.55B $2.43B $2.17B
Income Tax 12-point trend, -75.6% $250M $413M $836M $762M $485M $1.31B $763M $391M $1.57B $938M $1.16B $1.02B
Net Income 12-point trend, +3.6% $1.19B $1.21B $2.49B $2.81B $2.93B $3.37B $2.71B $1.68B $2.45B $614M $1.28B $1.15B
EPS (Basic) 12-point trend, +32.7% $9.87 $10.01 $20.09 $22.20 $22.79 $25.47 $20.20 $12.24 $16.94 $4.11 $8.54 $7.44
EPS (Diluted) 12-point trend, +33.7% $9.84 $9.98 $20.00 $22.08 $22.67 $25.31 $20.10 $12.16 $16.81 $4.07 $8.44 $7.36
Shares (Basic) 12-point trend, -21.9% 120,454,000 120,571,000 123,866,000 126,419,000 128,688,000 132,199,000 134,055,000 137,486,000 144,493,000 149,375,000 149,455,000 154,187,000
Shares (Diluted) 12-point trend, -22.5% 120,826,000 120,869,000 124,441,000 127,094,000 129,396,000 133,012,000 134,727,000 138,403,000 145,585,000 150,917,000 151,142,000 155,874,000
EBITDA 12-point trend, +14.5% $2.70B $2.56B $4.01B $3.80B $3.15B $4.99B $3.19B $3.10B $4.26B $1.74B $2.35B $2.36B
Balance Sheet 26
Annual Balance Sheet data for HUM
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +117.1% $4.20B $2.22B $4.69B $5.06B $3.39B $4.67B $4.05B $2.34B $4.04B $3.88B $2.57B $1.94B
Short-term Investments 7-point trend, +43.1% $15.70B $18.21B $16.63B $13.88B $13.19B $12.55B $10.97B · · · · ·
Receivables 12-point trend, +210.5% $3.27B $2.70B $2.04B $1.67B $1.81B $1.14B $1.06B $1.01B $854M $1.28B $1.16B $1.05B
Other Current Assets 12-point trend, +138.6% $9.56B $6.68B $6.63B $5.57B $6.49B $5.28B $3.81B $3.56B $2.95B $3.44B $4.71B $4.01B
Current Assets 12-point trend, +110.7% $32.73B $29.82B $29.99B $26.18B $24.89B $23.64B $19.89B $16.95B $17.40B $16.19B $15.71B $15.54B
PP&E (Net) 12-point trend, +81.7% $2.23B $2.53B $3.03B $3.22B $3.07B $2.37B $1.96B $1.74B $1.58B $1.50B $1.38B $1.23B
PP&E (Gross) 12-point trend, +89.9% $5.52B $5.67B $5.88B $6.36B $5.95B $5.49B $4.62B $4.05B $3.56B $3.19B $2.72B $2.91B
Accum. Depreciation 12-point trend, +95.8% $3.29B $3.14B $2.85B $3.14B $2.87B $3.12B $2.66B $2.31B $1.98B $1.69B $1.34B $1.68B
Goodwill 12-point trend, +199.8% $9.69B $9.63B $9.55B $9.14B $11.09B $4.45B $3.93B $3.90B $3.28B $3.27B $3.27B $3.23B
Intangibles 12-point trend, +156.4% $1.13B $1.44B $1.69B $1.76B $2.64B $329M $177M $245M $226M $280M $357M $440M
Other Non-current Assets 12-point trend, +97.6% $3.13B $3.38B $3.38B $3.38B $4.38B $2.13B $1.83B $1.38B $2.17B $2.23B $2.48B $1.58B
Total Assets 12-point trend, +107.9% $48.91B $46.48B $47.06B $43.05B $44.36B $34.97B $29.07B $25.41B $27.18B $25.40B $24.68B $23.53B
Accounts Payable 12-point trend, +172.9% $5.72B $5.26B $6.57B $5.24B $4.51B $4.01B $3.75B $3.07B $4.07B $2.47B $2.21B $2.10B
Short-term Debt 5-point trend, +1694000000.00 · · · · · · · $1.69B $150M $300M $299M $0
Current Liabilities 12-point trend, +118.8% $16.35B $16.94B $18.87B $17.18B $15.33B $13.39B $10.93B $10.08B $9.41B $7.82B $8.15B $7.47B
Capital Leases 7-point trend, +25.9% $418M $392M $444M $456M $546M $355M $332M · · · · ·
Other Non-current Liabilities 12-point trend, +941.1% $2.46B $1.95B $1.66B $1.47B $2.38B $1.79B $1.14B $581M $237M $263M $235M $236M
Total Liabilities 12-point trend, +124.6% $31.17B $30.03B $30.75B $27.68B $28.25B $21.24B $17.04B $15.25B $17.34B $14.71B $14.33B $13.88B
Total Debt 12-point trend, +223.4% $12.37B $11.14B $10.21B $9.03B $10.54B $6.06B $4.97B $6.07B $4.92B $4.09B $4.12B $3.83B
Common Stock Flat — no change across 12 periods $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M
Retained Earnings 12-point trend, +193.2% $29.07B $28.32B $27.54B $25.49B $23.09B $20.52B $17.48B $15.07B $13.67B $11.45B $11.02B $9.92B
Treasury Stock 12-point trend, +404.8% $14.42B $14.37B $13.66B $12.16B $10.16B $9.92B $8.46B $7.32B $6.33B $3.30B $3.29B $2.86B
AOCI 12-point trend, -383.9% $-633M $-1.07B $-999M $-1.30B $42M $391M $156M $-159M $19M $-66M $58M $223M
Stockholders' Equity 12-point trend, +83.0% $17.66B $16.38B $16.26B $15.31B $16.08B $13.73B $12.04B $10.16B $9.84B $10.69B $10.35B $9.65B
Liabilities + Equity 12-point trend, +107.9% $48.91B $46.48B $47.06B $43.05B $44.36B $34.97B $29.07B $25.41B $27.18B $25.40B $24.68B $23.53B
Shares Outstanding 7-point trend, +0.0% 198,719,000 198,719,000 198,690,000 198,667,000 198,649,000 198,649,000 198,630,000 · · · · ·
Cash Flow 17
Annual Cash Flow data for HUM
Metric Trend 202520242023202220212020201920182017201620152014
D&A 10-point trend, +112.8% $698M $839M $779M $709M $596M · · $444M $410M $388M $354M $328M
Stock-based Comp 12-point trend, +145.9% $241M $207M $175M $216M $180M $181M $163M $137M $157M $115M $109M $98M
Deferred Tax 12-point trend, +217.2% $75M $-192M $-164M $-100M $15M $195M $162M $194M $132M $-71M $-2M $-64M
Amort. of Intangibles 12-point trend, -57.9% $51M $60M $67M $81M $65M $88M $70M $90M $75M $77M $93M $121M
Restructuring 2-point trend, -68.2% · · · · · · $47M · $148M · · ·
Operating Cash Flow 12-point trend, -43.1% $921M $2.97B $3.98B $4.59B $2.26B $5.64B $5.28B $2.17B $4.05B $1.94B $868M $1.62B
CapEx 12-point trend, +3.4% $546M $575M $1.00B $1.14B $1.34B $964M $736M $612M $524M $527M $523M $528M
Investing Cash Flow 12-point trend, +3707.9% $2.27B $-2.95B $-3.49B $-1.01B $-6.56B $-3.06B $-1.28B $-3.09B $-2.94B $-1.36B $320M $-63M
Net Debt Issued 6-point trend, +20.0% · · · · · · $-400M $0 $-800M $0 $0 $-500M
Stock Repurchased 12-point trend, -82.7% $151M $817M $1.57B $2.10B $79M $1.82B $1.07B $1.09B $3.37B $104M $385M $872M
Net Stock Activity 12-point trend, +82.7% $-151M $-817M $-1.57B $-2.10B $-79M $-1.82B $-1.07B $-1.09B $-3.37B $-104M $-385M $-872M
Dividends Paid 12-point trend, +150.0% $430M $431M $431M $392M $354M $323M $291M $265M $220M $177M $172M $172M
Financing Cash Flow 12-point trend, -60.3% $-1.22B $-2.49B $-856M $-1.91B $3.02B $-1.96B $-2.29B $-785M $-945M $732M $-552M $-758M
Net Change in Cash 12-point trend, +148.3% $1.98B $-2.47B $-367M $1.67B $-1.28B $619M $1.71B $-1.70B $165M $1.31B $636M $797M
Taxes Paid 11-point trend, -44.7% · $570M $997M $758M $227M $1.13B $518M $631M $1.50B $916M $1.18B $1.03B
Free Cash Flow 12-point trend, -65.6% $375M $2.39B $2.98B $3.47B $946M $4.67B $4.55B $1.56B $3.52B $1.41B $345M $1.09B
Levered FCF 10-point trend, +163.8% · · $2.61B $3.15B $666M $4.47B $4.36B $1.38B $3.38B $1.33B $247M $989M
Profitability 7
Annual Profitability data for HUM
Metric Trend 202520242023202220212020201920182017201620152014
Operating Margin 12-point trend, -57.1% 2.1% 2.2% 3.8% 4.1% 3.8% 6.5% 4.9% 5.5% 7.9% 3.2% 4.3% 4.9%
Net Margin 12-point trend, -61.0% 0.92% 1.0% 2.3% 3.0% 3.5% 4.4% 4.2% 3.0% 4.5% 1.1% 2.4% 2.4%
Pretax Margin 12-point trend, -75.2% 1.1% 1.5% 3.1% 3.8% 4.1% 6.1% 5.3% 3.6% 7.5% 2.9% 4.5% 4.5%
EBITDA Margin 12-point trend, -57.1% 2.1% 2.2% 3.8% 4.1% 3.8% 6.5% 4.9% 5.5% 7.9% 3.2% 4.3% 4.9%
ROA 12-point trend, -52.0% 2.5% 2.6% 5.5% 6.4% 7.4% 10.5% 9.9% 6.4% 9.3% 2.5% 5.3% 5.2%
ROE 12-point trend, -42.3% 7.0% 7.4% 15.8% 18.2% 18.1% 22.8% 22.9% 16.2% 23.3% 5.8% 12.8% 12.1%
ROIC 12-point trend, -19.7% 7.4% 7.1% 11.3% 12.3% 10.1% 18.1% 14.6% 15.5% 17.6% 4.7% 8.5% 9.3%
Liquidity & Solvency 5
Annual Liquidity & Solvency data for HUM
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +0.1% 2.0 1.8 1.6 1.5 1.6 1.8 1.8 1.7 1.9 2.1 1.9 2.0
Quick Ratio 12-point trend, +236.0% 1.4 1.4 1.2 1.2 1.2 1.4 0.5 0.3 0.5 0.7 0.5 0.4
Debt / Equity 12-point trend, +76.7% 0.7 0.7 0.6 0.6 0.7 0.4 0.4 0.6 0.5 0.4 0.4 0.4
LT Debt / Equity 12-point trend, +76.7% 0.7 0.7 0.6 0.6 0.7 0.4 0.4 0.4 0.5 0.4 0.4 0.4
Interest Coverage 10-point trend, -33.8% · · 8.1 9.5 9.7 17.6 13.2 14.2 17.6 9.2 12.6 12.3
Efficiency 2
Annual Efficiency data for HUM
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, +23.9% 2.7 2.5 2.4 2.1 2.1 2.4 2.4 2.2 2.0 2.2 2.3 2.2
Receivables Turnover 12-point trend, -5.2% 43.4 49.7 57.4 53.3 56.3 70.3 62.7 60.9 50.4 44.6 49.0 45.8
Per Share 7
Annual Per Share data for HUM
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share 4-point trend, +15.3% $88.85 $82.40 $81.85 $77.07 · · · · · · · ·
Revenue / Share 12-point trend, +244.9% $1073.15 $974.29 $854.81 $730.72 $641.94 $580.06 $481.63 $411.20 $369.32 $360.32 $359.19 $311.15
Cash Flow / Share 12-point trend, -26.6% $7.62 $24.54 $31.99 $36.09 $17.48 $42.39 $39.22 $15.70 $27.83 $12.83 $5.74 $10.38
Cash / Share 4-point trend, -17.0% $21.14 $11.18 $23.62 $25.47 · · · · · · · ·
Dividend / Share 3-point trend, +4.5% · · · · · · · · · $1 $1 $1
Dividend Paid / Share 12-point trend, +221.8% $4 $4 $3 $3 $3 $2 $2 $2 $1 $1 $1 $1
EPS (TTM) 12-point trend, +33.7% $9.84 $9.98 $20.00 $22.08 $22.67 $25.31 $20.10 $12.16 $16.81 $4.07 $8.44 $7.36
Growth Rates 10
Annual Growth Rates data for HUM
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +32.0% 10.1% 10.7% 14.5% 11.8% 7.7% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +4.2% 11.8% 12.3% 11.3% · · · · · · · · ·
Revenue CAGR 5Y 10.9% · · · · · · · · · · ·
EPS YoY 5-point trend, +86.6% -1.4% -50.1% -9.4% -2.6% -10.4% · · · · · · ·
EPS CAGR 3Y 3-point trend, -212.8% -23.6% -23.9% -7.5% · · · · · · · · ·
EPS CAGR 5Y -17.2% · · · · · · · · · · ·
Net Income YoY 5-point trend, +87.8% -1.6% -51.5% -11.3% -4.3% -12.9% · · · · · · ·
Net Income CAGR 3Y 3-point trend, -160.0% -24.9% -25.6% -9.6% · · · · · · · · ·
Net Income CAGR 5Y -18.8% · · · · · · · · · · ·
Dividend CAGR 5Y 5.9% · · · · · · · · · · ·
Valuation (TTM) 17
Annual Valuation (TTM) data for HUM
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +167.3% $129.66B $117.76B $106.37B $92.87B $83.06B $77.16B $64.89B $56.91B $53.77B $54.38B $54.29B $48.50B
Net Income TTM 12-point trend, +3.6% $1.19B $1.21B $2.49B $2.81B $2.93B $3.37B $2.71B $1.68B $2.45B $614M $1.28B $1.15B
Market Cap 4-point trend, -50.0% $50.90B $50.42B $90.96B $101.76B · · · · · · · ·
Enterprise Value 4-point trend, -52.8% $43.36B $41.13B $79.86B $91.85B · · · · · · · ·
P/E 12-point trend, +33.4% 26.0 25.4 22.9 23.2 20.5 16.2 18.2 23.6 14.8 50.1 21.2 19.5
P/S 4-point trend, -64.2% 0.4 0.4 0.9 1.1 · · · · · · · ·
P/B 4-point trend, -56.6% 2.9 3.1 5.6 6.6 · · · · · · · ·
P / Tangible Book 4-point trend, -67.8% 7.4 9.5 18.1 23.1 · · · · · · · ·
P / Cash Flow 4-point trend, +149.1% 55.3 17.0 22.8 22.2 · · · · · · · ·
P / FCF 4-point trend, +362.5% 135.7 21.1 30.6 29.3 · · · · · · · ·
EV / EBITDA 4-point trend, -33.7% 16.0 16.1 19.9 24.2 · · · · · · · ·
EV / FCF 4-point trend, +336.5% 115.6 17.2 26.8 26.5 · · · · · · · ·
EV / Revenue 4-point trend, -66.2% 0.3 0.3 0.8 1.0 · · · · · · · ·
Dividend Yield 4-point trend, +115.4% 0.84% 0.85% 0.47% 0.39% · · · · · · · ·
Earnings Yield 12-point trend, -25.0% 3.8% 3.9% 4.4% 4.3% 4.9% 6.2% 5.5% 4.2% 6.8% 2.0% 4.7% 5.1%
Payout Ratio 12-point trend, +141.3% 36.2% 35.7% 17.3% 14.0% 12.1% 9.6% 10.8% 15.8% 9.0% 28.8% 13.5% 15.0%
Annual Payout 12-point trend, +150.0% $430M $431M $431M $392M $354M $323M $291M $265M $220M $177M $172M $172M

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $129.66B$117.76B$106.37B$92.87B$83.06B
Operating Margin % 2.1%2.2%3.8%4.1%3.8%
Net Income $1.19B$1.21B$2.49B$2.81B$2.93B
Diluted EPS $9.84$9.98$20.00$22.08$22.67
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity 0.70.70.60.60.7
Current Ratio 2.01.81.61.51.6
Quick Ratio 1.41.41.21.21.2
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $375M$2.39B$2.98B$3.47B$946M

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 1,050 filers · $33.7B total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
255 (+136 vs prior Q) 83 (-77 vs prior Q) 316 (+44 vs prior Q) 274 (-45 vs prior Q) +8.8M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Dodge & Cox $4,345,737,744 10,940,380 12.89% Shares
VANGUARD CAPITAL MANAGEMENT LLC $3,115,642,737 7,843,620 9.24% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $2,311,405,702 5,818,956 6.86% Shares
STATE STREET CORP $2,172,441,313 5,457,072 6.45% Shares
EAGLE CAPITAL MANAGEMENT LLC $1,528,010,749 3,846,762 4.53% Shares
Sessa Capital IM, L.P. $1,480,732,883 3,727,740 4.39% Shares
GEODE CAPITAL MANAGEMENT, LLC $1,181,074,714 2,976,242 3.50% Shares
Capital International Investors $950,462,637 2,392,826 2.82% Shares
NAYA CAPITAL MANAGEMENT UK LTD $728,407,339 1,833,763 2.16% Shares
NORGES BANK $694,505,009 1,748,414 2.06% Shares
GOLDMAN SACHS GROUP INC $659,096,868 1,659,274 1.96% Shares
FMR LLC $615,633,048 1,549,854 1.83% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $544,502,820 1,370,784 1.62% Shares
Capital Research Global Investors $443,462,035 1,116,990 1.32% Shares
Slate Path Capital LP $428,969,795 1,079,930 1.27% Shares
Capital World Investors $406,119,738 1,022,425 1.21% Shares
Newport Trust Company, LLC $384,768,345 968,653 1.14% Shares
CITADEL ADVISORS LLC $363,376,856 914,800 1.08% Call option
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $348,908,912 878,377 1.04% Shares
DIMENSIONAL FUND ADVISORS LP $331,490,508 834,526 0.98% Shares
BARROW HANLEY MEWHINNEY & STRAUSS LLC $314,921,577 792,814 0.93% Shares
CITADEL ADVISORS LLC $310,904,094 782,700 0.92% Put option
WELLINGTON MANAGEMENT GROUP LLP $282,117,958 710,231 0.84% Shares
VANGUARD FIDUCIARY TRUST CO $267,791,027 674,163 0.79% Shares
Maple Rock Capital Partners Inc. $249,553,862 628,251 0.74% Shares
Diamond Hill Capital Management, LLC (Investment Advisor) $245,555,446 618,185 0.73% Shares
GOLDMAN SACHS GROUP INC $232,333,978 584,900 0.69% Call option
MARSHALL WACE, LLP $216,873,381 545,978 0.64% Shares
CITADEL ADVISORS LLC $178,080,082 448,316 0.53% Shares
High Ground Investment Management LLP $177,941,848 447,968 0.53% Shares
1832 Asset Management L.P. $176,401,430 444,090 0.52% Shares
BCV Asset Management Inc. $173,695,656 445,719 0.52% Shares
BANK OF AMERICA CORP /DE/ $172,703,708 434,781 0.51% Shares
Holocene Advisors, LP $165,040,541 415,489 0.49% Shares
BNP PARIBAS FINANCIAL MARKETS $147,490,964 371,308 0.44% Shares
MILLENNIUM MANAGEMENT LLC $140,098,700 352,698 0.42% Shares
JANE STREET GROUP, LLC $137,080,622 345,100 0.41% Call option
Swiss National Bank $134,522,525 338,660 0.40% Shares
JANE STREET GROUP, LLC $122,542,370 308,500 0.36% Put option
STEADFAST CAPITAL MANAGEMENT LP $122,423,204 308,200 0.36% Shares
BlackRock, Inc. $120,890,332 304,341 0.36% Shares
Mitsubishi UFJ Asset Management Co., Ltd. $115,565,201 290,935 0.34% Shares
VANGUARD ASSET MANAGEMENT, Ltd $109,135,401 274,748 0.32% Shares
AMERIPRISE FINANCIAL INC $108,302,217 272,614 0.32% Shares
Legal & General Group Plc $103,424,967 260,372 0.31% Shares
Vanguard Global Advisers, LLC $103,330,825 260,135 0.31% Shares
GOLDMAN SACHS GROUP INC $103,078,590 259,500 0.31% Put option
NEUBERGER BERMAN GROUP LLC $102,585,352 258,258 0.30% Shares
BANK OF NOVA SCOTIA $102,313,941 257,575 0.30% Shares
RHUMBLINE ADVISERS $102,294,748 257,527 0.30% Shares
Sumitomo Mitsui Trust Group, Inc. $101,464,685 255,437 0.30% Shares
GLENVIEW CAPITAL MANAGEMENT, LLC $100,979,680 254,216 0.30% Shares
Gotham Asset Management, LLC $89,318,889 224,860 0.27% Shares
Balyasny Asset Management L.P. $87,965,958 221,454 0.26% Shares
FIRST TRUST ADVISORS LP $85,094,587 214,226 0.25% Shares
Ensign Peak Advisors, Inc $83,532,585 210,293 0.25% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $83,463,866 210,120 0.25% Shares
Brandywine Global Investment Management, LLC $80,388,706 313,859 0.24% Shares
California Public Employees Retirement System $80,274,587 202,091 0.24% Shares
WOLVERINE TRADING, LLC $76,135,109 298,300 0.23% Call option
Camber Capital Management LP $73,344,000 300,000 0.22% Shares
National Pension Service $70,860,473 178,391 0.21% Shares
BARCLAYS PLC $70,472,788 177,415 0.21% Shares
Susquehanna Portfolio Strategies, LLC $69,949,250 176,097 0.21% Shares
Walleye Trading LLC $69,473,778 174,900 0.21% Call option
CANADA PENSION PLAN INVESTMENT BOARD $68,018,761 171,237 0.20% Shares
ARGA Investment Management, LP $66,165,730 166,572 0.20% Shares
ORBIMED ADVISORS LLC $65,183,802 164,100 0.19% Shares
Solel Partners LP $64,742,888 162,990 0.19% Shares
AMF Tjanstepension AB $61,961,951 155,989 0.18% Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $60,794,124 153,049 0.18% Shares
Perpetual Ltd $57,945,659 145,878 0.17% Shares
CI INVESTMENTS INC. $57,302,560 144,259 0.17% Shares
AMERICAN CENTURY COMPANIES INC $56,575,256 142,426 0.17% Shares
Squarepoint Ops LLC $56,047,742 141,100 0.17% Put option
Aberdeen Group plc $53,345,852 134,298 0.16% Shares
WOLVERINE TRADING, LLC $52,653,949 206,300 0.16% Put option
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $52,178,000 131,358 0.15% Shares
ING GROEP NV $51,583,784 129,862 0.15% Shares
Squarepoint Ops LLC $50,685,272 127,600 0.15% Call option
Walleye Trading LLC $49,573,056 124,800 0.15% Put option
D. E. Shaw & Co., Inc. $46,514,462 117,100 0.14% Call option
BRAIDWELL LP $45,481,690 114,500 0.13% Shares
Jain Global LLC $43,694,200 110,000 0.13% Put option
BANK OF MONTREAL /CAN/ $43,207,208 108,774 0.13% Shares
Zurcher Kantonalbank (Zurich Cantonalbank) $42,190,325 106,214 0.13% Shares
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $42,127,167 106,055 0.12% Shares
AVIVA PLC $41,509,093 104,499 0.12% Shares
VIRGINIA RETIREMENT SYSTEMS ET Al $41,468,472 161,904 0.12% Shares
ROYAL BANK OF CANADA $41,033,000 103,301 0.12% Shares
Pentwater Capital Management LP $39,722,000 100,000 0.12% Call option
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $39,284,661 98,899 0.12% Shares
Point72 Asset Management, L.P. $39,122,595 98,491 0.12% Shares
PFM Health Sciences, LP $37,487,638 94,375 0.11% Shares
Summit Street Capital Management, LLC $36,325,372 91,449 0.11% Shares
Columbus Hill Capital Management, L.P. $35,501,935 89,376 0.11% Shares
Korea Investment CORP $34,579,193 87,053 0.10% Shares
Quantinno Capital Management LP $32,817,091 82,616 0.10% Shares
Fisher Funds Management LTD $32,811,563 82,603 0.10% Shares
Swedbank AB $32,034,603 80,647 0.10% Shares

Company insiders 76 insiders · 46 officers · 27 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
James A. Rechtin President & CEO May 14, 2025 P 30,474 0 0 $0
Bruce D Broussard Chief Executive Officer Feb. 21, 2024 A 110,130 0 0 $0
Celeste Mellet Chief Financial Officer Feb. 24, 2025 A 29,676 0 0 $0
Susan M Diamond Chief Financial Officer Dec. 31, 2024 J 20,165 0 0 $0
Brian A Kane Chief Financial Officer Feb. 22, 2021 A 24,342 0 0 $0
Steven E Mcculley Interim CFO & Treasurer May 9, 2014 G 14,916 0 0 $0
George Renaudin II President, Insurance March 27, 2025 J 15,702 0 0 $0
David Dintenfass President, Enterprise Growth Feb. 24, 2025 A 16,234 0 0 $0
Sanjay K Shetty President, CenterWell Feb. 24, 2025 A 11,566 0 0 $0
M.D. Andrew C. Agwunobi, Seg. President, Home Solutions Feb. 24, 2023 A 182 0 0 $0
Timothy Alan Wheatley Segment President, Retail Dec. 15, 2022 M 3,983 0 0 $0
Joseph William Jasser Seg. President, Care Delivery Dec. 15, 2017 M 222 0 0 $0
Thomas J Liston President - Retail Segment Feb. 18, 2014 A 105,443 0 0 $0
James E Murray EVP & COO March 31, 2017 J 34,668 0 0 $0
Japan Mehta Chief Information Officer Feb. 24, 2025 A 8,628 0 0 $0
John-Paul W. Felter SVP, Chief Accting Off & Cont. Feb. 24, 2025 A 1,767 0 0 $0
Michelle A. O'Hara Chief Human Resources Officer Feb. 24, 2025 A 11,266 0 0 $0
Joseph C Ventura Chief Legal Officer Feb. 24, 2025 A 17,267 0 0 $0
Vishal Agrawal Chief Strat & Corp Dev Officer Feb. 24, 2025 A 16,717 0 0 $0
Timothy S. Huval Chief Administrative Officer Dec. 31, 2024 G 7,111 0 0 $0
Samir Deshpande Chief Information Officer Dec. 15, 2024 M 14,015 0 0 $0
William Kevin Fleming Chief Corporate Aff. Officer Feb. 21, 2024 A 11,723 0 0 $0
Susan D. Schick Seg Pres. Grp. & Military Bus. Feb. 24, 2023 F 3,687 0 0 $0
William H Shrank Chief Medical Officer May 1, 2022 M 4,294 0 0 $0
Cynthia H Zipperle SVP, Chief Acct Officer & Cont March 22, 2022 J 5,723 0 0 $0
Heather Cox Chief Dig Health & Analyt Off. Feb. 25, 2022 F 6,014 0 0 $0
Christopher H. Hunter Seg Pres. Gr. & Military Bus. March 16, 2021 G 8,168 0 0 $0
Elizabeth D Bierbower Strategic Advisor Dec. 18, 2019 M 18,092 0 0 $0
Brian P. Leclaire Strategic Advisor Dec. 15, 2019 M 6,339 0 0 $0
Jody L Bilney Chief Consumer Officer Feb. 25, 2019 A 9,774 0 0 $0
Roy A Beveridge, Chief Medical Officer Feb. 19, 2019 M 10,791 0 0 $0
Todoroff M Christopher Chief Legal Officer Dec. 15, 2018 M 11,136 0 0 $0
Heidi S Margulis Chief Corp. Affairs Officer Dec. 15, 2018 M 6,476 0 0 $0
Christopher E Kay SVP & Chief Innovation Officer March 17, 2017 M 4,361 0 0 $0
Tim S Mcclain Group Pres, Govt & Other Busin Feb. 18, 2014 A 1,101 0 0 $0
Bruce D Perkins Sgmt Pres, Healthcare Services Feb. 18, 2014 A 15,946 0 0 $0
Paul B. K. Kusserow Sr VP & Ch Strat Dev Officer June 24, 2013 M 19,347 0 0 $0
HATHCOCK BONNIE C Sr VP & Chief Human Res. Off Dec. 24, 2012 G 2,287 0 0 $0
Venkata R Madabhushi SVP & Chief Innov & Mrkting Of April 28, 2012 F 11,946 0 0 $0
GOODMAN BRUCE J Sr. VP Feb. 23, 2012 A 23,280 0 0 $0
Jonathan T Lord MD Sr VP & Chief Innovation Off. Feb. 4, 2009 I 0 0 0 $0
Arthur P Hipwell Senior Vice President March 27, 2008 J 302 0 0 $0
Kathleen Pellegrino VP and Acting General Counsel Feb. 25, 2008 F 13,836 0 0 $0
Steven O Moya Sr. VP-Chief Marketing Officer Dec. 31, 2007 I 0 0 0 $0
John M Bertko Vice President & Chief Actuary Feb. 23, 2007 M 57,548 0 0 $0
Eugene R Shields Senior Vice President-Gov Prgm Jan. 6, 2005 M 0 0 0 $0
Kurt J Hilzinger Director June 30, 2026 A 19,448 0 0 $0
Frank A Damelio Director Jan. 2, 2026 A 20,634 0 0 $0
Karen Katz Director Dec. 31, 2025 A 590 0 0 $0
David T Feinberg Director June 30, 2025 A 441 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 1 position

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
David A. Jones ×2 filings Nov. 12, 2003 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 199 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
FXH · First Trust Exchange-Traded AlphaDE… 2.95% 109,132 NS April 30, 2026 N-PORT
SMRI · EA Series Trust 2.54% 58,016 NS April 30, 2026 N-PORT
TGLB · T. Rowe Price Exchange-Traded Funds… 2.26% 2,111 NS April 30, 2026 N-PORT
SRHQ · Elevation Series Trust 1.63% 13,322 NS April 30, 2026 N-PORT
CVAR · ETF Opportunities Trust 1.51% 2,473 NS April 30, 2026 N-PORT
HWSM · HOTCHKIS & WILEY FUNDS /DE/ 1.23% 85 NS June 30, 2026 N-PORT
EPMV · Harbor ETF Trust 1.20% 225 NS April 30, 2026 N-PORT
ABCS · EA Series Trust 1.19% 441 NS May 29, 2026 N-PORT
MFSV · MFS Active Exchange Traded Funds Tr… 1.14% 17,702 NS May 31, 2026 N-PORT
NUMV · Nushares ETF Trust 0.96% 17,434 NS April 30, 2026 N-PORT
FTA · First Trust Exchange-Traded AlphaDE… 0.95% 52,223 NS April 30, 2026 N-PORT
ITAN · EA Series Trust 0.77% 2,259 NS May 29, 2026 N-PORT
CGMM · Capital Group Equity ETF Trust I 0.72% 65,925 NS May 31, 2026 N-PORT
AUSF · Global X Funds 0.70% 19,401 NS May 31, 2026 N-PORT
AVIE · AMERICAN CENTURY ETF TRUST 0.63% 211 NS May 31, 2026 N-PORT
FVAL · FIDELITY COVINGTON TRUST 0.59% 30,459 NS April 30, 2026 N-PORT
RXL · ProShares Trust 0.53% 1,258 NS May 31, 2026 N-PORT
FAB · First Trust Exchange-Traded AlphaDE… 0.47% 2,755 NS April 30, 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0.46% 55,439 NS April 30, 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0.45% 28,340 NS April 30, 2026 N-PORT
DEUS · DBX ETF Trust 0.43% 3,849 NS May 29, 2026 N-PORT
CURE · Direxion Shares ETF Trust 0.41% 2,404 NS April 30, 2026 N-PORT
SPXD · DBX ETF Trust 0.37% 81 NS May 31, 2026 N-PORT
QARP · DBX ETF Trust 0.36% 887 NS May 29, 2026 N-PORT
AVMC · AMERICAN CENTURY ETF TRUST 0.34% 4,484 NS May 31, 2026 N-PORT
GMOV · GMO ETF Trust 0.34% 1,004 NS May 31, 2026 N-PORT
FNDX · SCHWAB STRATEGIC TRUST 0.32% 265,500 NS May 31, 2026 N-PORT
FNDB · SCHWAB STRATEGIC TRUST 0.29% 12,439 NS May 31, 2026 N-PORT
PALC · Pacer Funds Trust 0.29% 2,779 NS April 30, 2026 N-PORT
SPVU · Invesco Exchange-Traded Fund Trust … 0.28% 1,250 NS May 31, 2026 N-PORT
BRCE · MFS Active Exchange Traded Funds Tr… 0.27% 299 NS May 31, 2026 N-PORT
FFLC · FIDELITY COVINGTON TRUST 0.26% 12,272 NS April 30, 2026 N-PORT
GSEW · Goldman Sachs ETF Trust 0.24% 14,039 NS May 31, 2026 N-PORT
AFLG · First Trust Exchange-Traded Fund VI… 0.21% 4,491 NS May 31, 2026 N-PORT
FLCV · Federated Hermes ETF Trust 0.20% 634 NS May 31, 2026 N-PORT
FLCC · Federated Hermes ETF Trust 0.18% 708 NS May 31, 2026 N-PORT
ROUS · Lattice Strategies Trust 0.16% 3,879 NS April 30, 2026 N-PORT
JVAL · J.P. Morgan Exchange-Traded Fund Tr… 0.15% 4,555 NS April 30, 2026 N-PORT
HELO · J.P. Morgan Exchange-Traded Fund Tr… 0.15% 24,794 NS April 30, 2026 N-PORT
CATH · Global X Funds 0.13% 6,791 NS April 30, 2026 N-PORT
DFLV · Dimensional ETF Trust 0.13% 32,836 NS April 30, 2026 N-PORT
SCHG · SCHWAB STRATEGIC TRUST 0.13% 256,808 NS May 31, 2026 N-PORT
ACVF · ETF Opportunities Trust 0.13% 790 NS April 30, 2026 N-PORT
OALC · Unified Series Trust 0.12% 945 NS May 31, 2026 N-PORT
DFSU · Dimensional ETF Trust 0.12% 10,240 NS April 30, 2026 N-PORT
GSLC · Goldman Sachs ETF Trust 0.11% 55,850 NS May 31, 2026 N-PORT
GVUS · Goldman Sachs ETF Trust 0.11% 1,461 NS May 31, 2026 N-PORT
USSG · DBX ETF Trust 0.11% 2,008 NS May 29, 2026 N-PORT
VEGN · ETF Series Solutions 0.10% 675 NS April 30, 2026 N-PORT
DFUV · Dimensional ETF Trust 0.09% 57,804 NS April 30, 2026 N-PORT